Clinical Trials Logo

Cutaneous Melanoma, Stage III clinical trials

View clinical trials related to Cutaneous Melanoma, Stage III.

Filter by:
  • Available  
  • Page 1

NCT ID: NCT04853602 Available - Clinical trials for Merkel Cell Carcinoma

IFx-Hu2.0 Expanded Access Program

Start date: n/a
Phase:
Study type: Expanded Access

Expanded access requests for IFx-Hu2.0 may be considered for the treatment of adult patients (greater than or equal to 18 years of age) with stage III through IV cutaneous melanoma, advanced Merkel cell carcinoma (MCC), or advanced cutaneous squamous cell carcinoma (cSCC) who have failed all available treatment options. To request access, use Responsible Party contact information provided in this record..